BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15997664)

  • 1. [Possibilities for cardiovascular gene therapy].
    Szelid ZL; Pokreisz P; Janssens S; Polák G
    Orv Hetil; 2005 May; 146(22):1189-96. PubMed ID: 15997664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential gene therapy strategies in the treatment of cardiovascular disease.
    Rowland RT; Cleveland JC; Meng X; Harken AH; Brown JM
    Ann Thorac Surg; 1995 Sep; 60(3):721-8. PubMed ID: 7677519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-targeted gene and cell-based therapies for cardiovascular disease.
    Melo LG; Gnecchi M; Pachori AS; Kong D; Wang K; Liu X; Pratt RE; Dzau VJ
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1761-74. PubMed ID: 15308553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial gene therapy.
    Isner JM
    Nature; 2002 Jan; 415(6868):234-9. PubMed ID: 11805848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does gene therapy become pharmacotherapy?
    Morishita R; Aoki M; Ogihara T
    Exp Physiol; 2005 May; 90(3):307-13. PubMed ID: 15778409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological approaches to ischemic tissue repair: gene- and cell-based strategies.
    Roncalli J; Tongers J; Renault MA; Losordo DW
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):653-68. PubMed ID: 18510483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for vascular disease.
    Heistad DD
    Vascul Pharmacol; 2006 Nov; 45(5):331-3. PubMed ID: 16996317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling ischemic cardiovascular disease: from basic mechanisms to clinical management.
    Beyar R
    Ann N Y Acad Sci; 2008 Mar; 1123():232-6. PubMed ID: 18375595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.
    Levonen AL; Vähäkangas E; Koponen JK; Ylä-Herttuala S
    Circulation; 2008 Apr; 117(16):2142-50. PubMed ID: 18427144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer in the cardiovascular system: update 2000.
    Medin JA; Buttrick PM
    Heart Dis; 2000; 2(6):409-21. PubMed ID: 11728292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of beta-adrenergic signaling components for heart failure.
    Koch WJ
    J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions.
    Kinnaird T; Stabile E; Zbinden S; Burnett MS; Epstein SE
    Cardiovasc Res; 2008 May; 78(2):257-64. PubMed ID: 18178573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell- and gene therapy for ischemic heart disease.
    Bonaros N; Bernecker O; Ott H; Schlechta B; Kocher AA
    Minerva Cardioangiol; 2005 Aug; 53(4):265-73. PubMed ID: 16177671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.